VITAL

Vital Chemtech Share Price

 

 

Start SIP in VITAL

Start SIP

Performance

  • Low
  • ₹57
  • High
  • ₹61
  • 52 Week Low
  • ₹48
  • 52 Week High
  • ₹78
  • Open Price₹60
  • Previous Close₹60
  • Volume7,200

Investment Returns

  • Over 1 Month -8.11%
  • Over 3 Month + 2.69%
  • Over 6 Month -12%
  • Over 1 Year -25.33%

Smart Investing Starts Here Start SIP with Vital Chemtech for Steady Growth!

Invest Now

Vital Chemtech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 33.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 137
  • P/B Ratio
  • Average True Range
  • 2.28
  • EPS
  • 1.69
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.69
  • RSI
  • 56.31
  • MFI
  • 69.33

Vital Chemtech Financials

Vital Chemtech Technicals

EMA & SMA

Current Price
₹57.20
-3 (-4.98%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹57.62
  • 50 Day
  • ₹58.22
  • 100 Day
  • ₹59.45
  • 200 Day
  • ₹63.08

Resistance and Support

59.25 Pivot Speed
  • R3 64.15
  • R2 62.20
  • R1 61.20
  • S1 58.25
  • S2 56.30
  • S3 55.30

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vital Chemtech has an operating revenue of Rs. 296.73 Cr. on a trailing 12-month basis. An annual revenue growth of 34% is outstanding, Pre-tax margin of 5% is okay, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 44%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 13 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 126 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vital Chemtech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results & Others To consider other business matters. Final Dividend of Re. 0.50 per equity share.
2025-09-01 To consider ESOP & Others To consider other business matters. Final Dividend of Re. 0.50 per equity share.
2025-05-30 Audited Results & Others To consider other business matters. Final Dividend of Re. 0.50 per equity share.
2024-11-14 Quarterly Results & Others To consider other business matters. Final Dividend of Re. 0.50 per equity share.
2024-05-29 Audited Results & Dividend
Date Purpose Remarks
2024-09-13 FINAL Re.0.00 Final Dividend of Re. 0.50 per equity share.
2023-09-15 FINAL Recommended Final Dividend of 0.5 per equity share. Final Dividend of Re. 0.50 per equity share.
View Vital Chemtech Dividend History Arrow

Vital Chemtech F&O

Vital Chemtech Shareholding Pattern

73.43%
1.78%
20.75%
4.04%

About Vital Chemtech

  • NSE Symbol
  • VITAL
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Vipul Jatashanker Bhatt
  • ISIN
  • INE0L4K01016

Similar Stocks to Vital Chemtech

Vital Chemtech FAQs

Vital Chemtech share price is ₹57 As on 08 December, 2025 | 15:00

The Market Cap of Vital Chemtech is ₹137 Cr As on 08 December, 2025 | 15:00

The P/E ratio of Vital Chemtech is 33.8 As on 08 December, 2025 | 15:00

The PB ratio of Vital Chemtech is 1.5 As on 08 December, 2025 | 15:00

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23